Sponsors (6)
Introduced May 23, 2025 by Diana Harshbarger · Last progress May 23, 2025
The bill increases federal support for restorative reproductive medicine, fertility‑awareness education, research, and data/reporting—improving diagnosis, clinician training, and access in some areas—but risks redirecting Title X and other resources away from comprehensive family‑planning services, privileging contested approaches, raising administrative costs, and creating privacy and access tradeoffs for patients.
People seeking restorative reproductive care (women, men, and adolescents) would have increased access to services, trainings, and more clinics eligible for federal Title X grants, expanding where restorative reproductive medicine and fertility‑awareness services are offered.
Better diagnostic codes, updated CPT/HCPCS coding and payment incentives would improve documentation, reimbursement, and financial viability for providing comprehensive infertility diagnostics and restorative procedures, potentially lowering barriers to care.
Federal coordination and sustained research funding on reproductive conditions (including male infertility, endometriosis, PCOS, fibroids, maternal health, and environmental factors) will expand scientific knowledge and could lead to better treatments and outcomes over time.
Low‑income people and others relying on Title X could see reduced emphasis on contraception and abortion‑related services as federal funds, training, and program priorities shift toward fertility‑awareness and restorative approaches, risking narrower family‑planning access.
The bill privileges and promotes specific, sometimes contested restorative approaches (e.g., NaProTechnology) and fertility‑awareness methods, which could bias research, training, and clinical practice away from other evidence‑based reproductive‑health options.
New reporting, training, coding updates, grant expansions, and survey work will create administrative and compliance costs for HHS, clinics, and payers, potentially diverting limited resources from other programs or increasing burdens on safety‑net providers.
Based on analysis of 14 sections of legislative text.
Directs HHS to expand research, coding, training, and program eligibility for restorative reproductive medicine and fertility awareness methods, and protects providers who decline ART on conscience grounds.
Requires HHS to expand research, education, coding, data collection, and training in restorative reproductive medicine, fertility awareness–based methods, and male factor infertility; update medical billing codes and reimbursement models; broaden eligibility for Title X and teen pregnancy prevention grant programs to include entities focused on restorative reproductive medicine; and protects health care providers who decline participation in assisted reproductive technology (ART) on grounds of conscience. Sets deadlines (generally 1–3 years) for reports, code updates, training, and program changes, and directs recurring data reports every three years.